Thrombosis and Haemostasis, Inhaltsverzeichnis Thromb Haemost 2004; 91(01): 203-204DOI: 10.1055/s-0037-1614259 Case Report Schattauer GmbH Treatment of bleeding with recombinant factor VIIa in a patient with extensive burns Alessandra Bianchi , David Jackson , Peter Maitz , Govindasamy ThanakrishnanArtikel empfehlen Abstract Artikel einzeln kaufen Volltext Referenzen References 1 Niemi T, Svartling N, Syrjala M. et al. Haemostatic disturbances in burned patients during early excision and skin grafting. Blood Coagul Fibrinolysis 1998; 09 (01) 19-28. 2 Garcia-Avello A, Lorente JA, Cesar-Perez J. et al. Degree of hypercoagulability and hyperfibrinolysis is related to organ failure and prognosis after burn trauma. Thromb Res 1998; 89 (02) 59-64. 3 Lecumberri R, Panzio C, Paramo JA. et al. Acquired inhibitor of the intrinsic pathway in a non-haemophilic patient. Control of bleeding by recombinant factor VIIa. Br J Hematol 2002; 119 (01) 284-5. 4 Kenet G, Walden R, Eldad A. et al. Treatment of traumatic bleeding with recombinant factor VIIa. Lancet 1999; 354 9193 1879. 5 Hendriks HG, van der Maaten JM, de Wolf J. et al. An effective treatment of severe intractable bleeding after valve repair by one single dose of activated recombinant factor VII. Anesth Analg 2001; 93 (02) 287-9. 6 Deveras RA, Kessler CM. Reversal of warfarin-induced excessive anticoagulation with recombinant human factor VIIa concentrate. Ann Intern Med 2002; 137 (11) 884-8. 7 Waddington DP, McAuley FT, Hanley JP. et al. The use of recombinant factor VIIa in a Jehovah’s witness with auto-immune thrombocytopenia and post-splenectomy haemorrhage. Br J Hematol 2002; 119 (01) 286-8. 8 Patel RK, Savidge GF, Rangarajan S. Use of recombinant factor VIIa for post-operative haemorrhage in a patient with Glanzmann’s thrombasthenia and human leucocyte antigen antibodies. Br J Hematol 2001; 114 (01) 245-6.
